Table 3.
Percentage of target doses achieved by the drugs
Category | HF clinic | Other cardiology OPD | ||
---|---|---|---|---|
Baseline | At 12 months | Baseline | At 12 months | |
Beta blockers | ||||
0–25% | 55% | 17% | 23% | 17% |
26–50% | 27% | 36% | 52% | 36% |
51–75% | 8% | 26% | 19% | 36% |
76–100% | 10% | 21% | 6% | 11% |
ACEI/ARB | ||||
0–25% | 55% | 30% | 52% | 27% |
26–50% | 26% | 21% | 28% | 33% |
51–75% | 5% | 5% | 12% | 23% |
76–100% | 14% | 44% | 8% | 17% |
MRA | ||||
0–25% | - | - | - | - |
26–50% | 25% | 2% | 38% | 20% |
51–75% | - | - | - | - |
76–100% | 75% | 98% | 62% | 80% |
The percentage of target doses achieved by the patients in each study group by the end of the twelfth month. Here the patients have been divided into four categories based on the percentage of target dose attained as: 0–25%, 26–50%, 51–75%, 76–100%